Is the seric eosinophil cationic protein level a valuable tool of diagnosis in clinical practice?;Le dosage de la protéine cationique des éosinophiles est-il un marqueur utile pour l'interniste ?

Revue de Medecine Interne

Volumn 27, Issue 9, 2006, Pages 679-683

  Moneret Vautrin, D A ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Dosage; Eosinophilic cationic protein; Non allergic inflammation

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; EOSINOPHIL PROTEIN X; PEROXIDASE;

ALLERGIC ASTHMA; ATOPIC DERMATITIS; CHURG STRAUSS SYNDROME; CLINICAL PRACTICE; COLITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EOSINOPHIL; ESOPHAGITIS; FECES; FOOD ALLERGY; GASTROENTERITIS; GASTROINTESTINAL DISEASE; HAY FEVER; HUMAN; INTESTINE PARASITE; NOSE POLYP; NOSE SECRETION; PARASITOSIS; PERENNIAL RHINITIS; RESPIRATORY TRACT INFECTION; SEROLOGY; SHORT SURVEY; SPUTUM; STOMACH SECRETION; ASTHMA; BLOOD; CHEMISTRY; IMMUNOLOGY; INFLAMMATION; REVIEW;

ASTHMA; DERMATITIS, ATOPIC; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL-DERIVED NEUROTOXIN; FECES; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION; PEROXIDASES; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SPUTUM;

EID: 33748618952     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.02.007     Document Type: Short Survey

References (50)

1. Carreras E., Boix E., Navarro S., Rosenberg H.F., Cuchillo C.M., and Nogués M.V. Surface-exposed aminoacids of eosinophil cationic protein play a critical role in the inhibition of mammalian cell proliferation. Mol. Cell. Biochem. 272 (2005) 1-7
2. Prin L., Roumier A.S., and Capron M. Les éosinophiles dans les réactions immunes physiologiques et pathologiques. In: Vervloet D., and Magnan A. (Eds). Traité d'allergologie (2003), Médecine-Sciences Flammarion, Paris 255-272
3. Davis M.D., Plager D.A., George T.J., Weiss E.A., Gleich G.J., and Leiferman K.M. Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization. J. Allergy Clin. Immunol. 112 (2003) 988-994
4. Linder A., Venge P., and Deuschl H. Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis. Allergy 42 (1987) 583-590
5. Bachert C., Gevaert P., Holtappels G., Cuvelier C., and Van Cauwenberge P. Nasal polyposis: from cytokines to growth. Am. J. Rhinol. 14 (2000) 279-290
6. Palczynski C., Walusiak J., Ruta U., and Gorski P. Occupational asthma and rhinitis due to glutaraldehyde: changes in nasal lavage fluid after specific inhalatory challenge test. Allergy 56 (2001) 1186-1191
7. Bachert C., Van Kempen M., and Van Cauwenberge P. Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Int. Arch. Allergy Immunol. 118 (1999) 375-379
8. Tomassini M., Magrini L., De Petrillo G., Adriani E., Bonini S., and Balsano F. Serum levels of eosinophil cationic protein in allergic diseases and natural allergen exposure. J. Allergy Clin. Immunol. 97 (1996) 1350-1355
9. Van Hage-Hamsten M., Johansson E., Roquet A., Peterson C., Andersson M., Greiff L., et al. Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis. Clin. Exp. Allergy 32 (2002) 1448-1453
10. Kowalski M.L., Grzegorczyk J., Wojciechowska B., and Poniatowska M. Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients. Clin. Exp. Allergy 26 (1996) 807-814
11. Weber A., Kiefer J., Peters S., Schneider M., Bargon J., and May A. Eosinophilic cationic protein as a marker of nasal inflammation in patients with cystic fibrosis. Laryngoscope 109 (1999) 1696-1702
12. Wang D., Brihaye P., Smitz J., De Waele M., and Clement P. Inflammatory cells and mediator concentrations in nasal secretions of patients with cystic fibrosis. Acta Otolaryngol. 116 (1996) 472-476
13. Advenier D., Guichard C., Kemeny J.L., Tridon A., and Gilain L. Analysis of eosinophilia and ECP levels in blood and nasal secretions of 119 nasal polyposis patients. Ann. Otolaryngol. Chir. Cervicofac. 119 (2002) 322-329
14. Niehaus M.D., Gwaltney Jr. J.M., Hendley J.O., Newman M.J., Heymann P.W., Rakes G.P., et al. Lactoferrin and eosinophilic cationic protein in nasal secretions of patients with experimental rhinovirus colds, natural colds, and presumed acute community-acquired bacterial sinusitis. J. Clin. Microbiol. 38 (2000) 3100-3102
15. Wang C., Cao Q., Zhang H.Z., and Jiang R.F. Effects of volatile organic compounds inhalation on the inflammation biomarkers in nasal lavage fluids of decoration workers. Wei Sheng Yan Jiu 34 (2005) 55-57
16. Oh J.W., Lee H.B., Kim C.R., Yum M.K., Koh Y.J., Moon S.J., et al. Analysis of induced sputum to examine the effects of inhaled corticosteroid on airway inflammation in children with asthma. Ann. Allergy Asthma Immunol. 82 (1999) 491-496
17. Horak F., Toth J., Hirschwehr R., Marks B., Stubner U.P., Jager S., et al. Effect of continuous allergen challenge on clinical symptoms and mediator release in dust-mite-allergic patients. Allergy 53 (1998) 68-72
18. Lemiere C., Pizzichini M.M., Balkissoon R., Clelland L., Efthimiadis A., O'Shaughnessy D., et al. Diagnosing occupational asthma: use of induced sputum. Eur. Respir. J. 13 (1999) 482-488
19. Lonnkvist K., Anderson M., Hedlin G., and Svartengren M. Exhaled NO and eosinophil markers in blood, nasal lavage and sputum in children with asthma after withdrawal of budesonide. Pediatr. Allergy Immunol. 15 (2004) 351-358
20. Bartoli M.L., Bacci E., Carnevali S., Cianchetti S., Dente F.L., Di Franco A., et al. Clinical assessment of asthma severity partially corresponds to sputum eosinophilic airway inflammation. Respir. Med. 98 (2004) 184-193
21. Romagnoli M., Vachier I., Tarodo de la Fuente P., Meziane H., Chavis C., Bousquet J., et al. Eosinophilic inflammation in sputum of poorly controlled asthmatics. Eur. Respir. J. 20 (2002) 1370-1377
22. Gibson P.G., Simpson J.L., Hankin R., Powell H., and Henry R.L. Relationship between induced sputum eosinophils and the clinical pattern of childhood asthma. Thorax 58 (2003) 116-121
23. Meijer R.J., Postma D.S., Kauffman H.F., Arends L.R., Koeter G.H., and Kerstjens H.A. Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthma. Clin. Exp. Allergy 32 (2002) 1096-1103
24. Nagayama Y., Tsubaki T., Toba T., Nakayama S., and Kiyofumi O. Analysis of sputum taken from wheezy and asthmatic infants and children, with special reference to respiratory infections. Pediatr. Allergy Immunol. 12 (2001) 318-326
25. Meziane H., Maakel M.L., Vachier I., Bousquet J., and Chanez P. Sputum eosinophilia in Churg-Strauss syndrome. Respir. Med. 95 (2001) 799-801
26. Saiga T., and Shimizu Y. Activated eosinophils in vernal keratoconjunctivitis. Nippon Rinsho 51 (1993) 816-819
27. Acar N., Toker E., and Kazokoglu H. Tear and serum eosinophil cationic protein levels in seasonal allergic conjunctivitis. Eur. J. Ophthalmol. 13 (2003) 671-675
28. Heiligenhaus A., Schaller J., Mauss S., Engelbrecht S., Dutt J.E., Foster C.S., et al. Eosinophil granule proteins expressed in ocular cicatricial pemphigoid. Br. J. Ophthalmol. 82 (1998) 312-317
29. Majamaa H., Laine S., and Miettinen A. Eosinophil protein X and eosinophil cationic protein as indicators of intestinal inflammation in infants with atopic eczema and food allergy. Clin. Exp. Allergy 29 (1999) 1502-1506
30. Kapel N., Matarazzo P., Haouchine D., Abiola N., Guérin S., Magne D., et al. Fecal tumor necrosis factor alpha, eosinophil cationic protein and IgE levels in infants with cow's milk allergy and gastrointestinal manifestations. Clin. Chem. Lab. Med. 37 (1999) 29-32
31. Saarinen K.M., Sarnesto A., and Savilahti E. Markers of inflammation in the feces of infants with cow's milk allergy. Pediatr. Allergy Immunol. 13 (2002) 188-194
32. Magnusson J., Gellerstedt M., Ahlstedt S., Andersson B., Bengtsson U., Telemo E., et al. A kinetic study in adults with food hypersensitivity assessed as eosinophil activation in fecal samples. Clin. Exp. Allergy 33 (2003) 1052-1059
33. Bischoff S.C., Mayer J., Nguyen Q.T., Stolte M., and Manns M.P. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease. Am. J. Gastroenterol. 94 (1999) 3521-3529
34. Peterson C.G., Eklund E., Taha Y., Raab Y., and Carlson M. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease. Am. J. Gastroenterol. 97 (2002) 1755-1762
35. Venge P. Monitoring the allergic inflammation. Allergy 59 (2004) 26-32
36. Selnes A., and Dotterud L.K. No association between serum eosinophil cationic protein and atopic dermatitis or allergic rhinitis in an unselected population of children. J. Eur. Acad. Dermatol. Venereol. 19 (2005) 61-65
37. Pucci N., Novembre E., Cammarata M.G., Bernardini R., Monaco M.G., Calogero C., et al. Scoring atopic dermatitis in infants and young children: distinctive features of the SCORAD index. Allergy 60 (2005) 113-116
38. Vourdas D., Syrigou E., Potamianou P., Carat F., Batard T., Andre C., et al. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 53 (1998) 662-672
39. Shichijo K., Makiyama K., Wen C.Y., Matsuu M., Nakayama T., Ihara M.N., et al. Antibody to eosinophil cationic protein suppresses dextran sulphate sodium-induced colitis in rats. World J. Gastroenterol. 11 (2005) 4505-4510
40. Pronk-Admiraal C.J., Linskens R.K., Van Bodegraven A.A., Tuynman H.A., and Bartels P.C. Serum eosinophil cationic protein in active and quiescent ulcerative colitis. Clin. Chem. Lab. Med. 38 (2000) 619-622
41. Aydemir S.A., Tekin I.O., Numanoglu G., Borazan A., and Ustundag Y. Eosinophil infiltration, gastric juice and serum eosinophil cationic protein levels in Helicobacter pylori-associated chronic gastritis and gastric ulcer. Mediators Inflamm. 13 (2004) 369-372
42. Tischendorf F.W., Brattig N.W., Burchard G.D., Kubica T., Kreuzpaintner G., and Kintzel M. Eosinophils, eosinophil cationic protein and eosinophil-derived neutotoxin in serum and urine of patients with onchocerciasis coinfected with intestinal nematodes and in urinary schistosomiasis. Acta Trop. 72 (1999) 157-173
43. Bischler K.H., Feil G., Zumbrägel A., Eipper E., and Dyballa S. Schistosomiasis: critical review. Curr. Opin. Urol. 11 (2001) 97-101
44. Magnaval J.F., Berry A., Fabre R., and Morassin B. Eosinophil cationic protein as a possible marker of active human Toxocara infection. Allergy 56 (2001) 1096-1099
45. Dominguez-Ortega J., Martinez-Alonso J.C., Alonso-Llamazares A., Argüelles-Grande C., Chamorro M., and Robledo T. Measurement of serum levels of eosinophil cationic protein in the diagnosis of acute gastrointestinal anisakiasis. Clin. Microbiol. Infect. 9 (2003) 453-457
46. Kwon N.H., Oh M.J., Lee S.P., Lee B.J., and Choi D.C. The prevalence and diagnostic value of toxocariasis in unknown eosinophilia. Ann. Hematol. 85 (2006) 233-238
47. Carlson M., Oberg G., Peterson C., and Venge P. Releasability of human hypereosinophilic eosinophils is related to the density of the cells. Br. J. Haematol. 86 (1994) 41-47
48. Bobbio-Pallavicini E., Confalonieri M., Tacconi F., Mainardi E., Della Porta R., Ceccato D., et al. Study of release of eosinophil cationic proteins (ECP and EPX) in the hypereosinophilic syndrome (HES) and other hypereosinophilic conditions. Panminerva Med. 40 (1998) 186-190
49. Confalonieri M., Tacconi F., De Amici M., Maccario R., Porta C., Gioglio L., et al. Benign idiopathic hypereosinophilia: a feeble masquerader or a smouldering form of the hypereosinophilic syndrome?. Haematologica 80 (1995) 50-53
50. Taniuchi S., Chihara J., Kojima T., Yamamoto A., Sasai M., and Kobayashi Y. Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein. J. Dermatol. Sci. 26 (2001) 79-82